Wright Investors Service’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$817K Sell
33,944
-41,056
-55% -$1.07M 0.22% 94
2026
Q1
$2.11M Sell
75,000
-4,263
-5% -$113K 0.66% 39
2025
Q4
$1.97M Buy
79,263
+56,743
+252% +$1.43M 0.59% 42
2025
Q3
$574K Sell
22,520
-1,949
-8% -$48.1K 0.17% 111
2025
Q2
$593K Buy
24,469
+119
+0.5% +$2.77K 0.18% 101
2025
Q1
$617K Buy
24,350
+7,465
+44% +$195K 0.2% 94
2024
Q4
$448K Buy
+16,885
New +$458K 0.15% 118
2024
Q2
Sell
-23,067
Closed -$640K 155
2024
Q1
$640K Sell
23,067
-27,882
-55% -$774K 0.16% 118
2023
Q4
$1.47M Buy
50,949
+3,127
+7% +$94.5K 0.41% 72
2023
Q3
$1.59M Sell
47,822
-825
-2% -$29.2K 0.46% 65
2023
Q2
$1.78M Sell
48,647
-709
-1% -$27.6K 0.5% 68
2023
Q1
$2.01M Buy
49,356
+1,482
+3% +$64K 0.57% 60
2022
Q4
$2.45M Sell
47,874
-1,533
-3% -$73.5K 0.7% 55
2022
Q3
$2.16M Sell
49,407
-16,413
-25% -$798K 0.68% 51
2022
Q2
$3.45M Buy
65,820
+3,023
+5% +$154K 0.99% 29
2022
Q1
$3.25M Buy
62,797
+23,259
+59% +$1.21M 0.81% 43
2021
Q4
$2.33M Sell
39,538
-146
-0.4% -$7.23K 0.59% 59
2021
Q3
$1.71M Buy
39,684
+9,161
+30% +$406K 0.49% 70
2021
Q2
$1.2M Buy
+30,523
New +$1.19M 0.32% 91
2019
Q4
Sell
-17,427
Closed -$594K 153
2019
Q3
$594K Sell
17,427
-52,969
-75% -$1.93M 0.21% 106
2019
Q2
$2.89M Buy
70,396
+3,953
+6% +$157K 1.1% 25
2019
Q1
$2.68M Sell
66,443
-7,809
-11% -$313K 1.08% 29
2018
Q4
$3.08M Sell
74,252
-1,232
-2% -$51.1K 1.32% 22
2018
Q3
$3.16M Buy
75,484
+3,105
+4% +$120K 1.15% 29
2018
Q2
$2.49M Sell
72,379
-367
-0.5% -$12.5K 0.99% 35
2018
Q1
$2.45M Buy
72,746
+6,735
+10% +$232K 0.84% 39
2017
Q4
$2.27M Sell
66,011
-822
-1% -$28K 0.76% 42
2017
Q3
$2.26M Buy
66,833
+940
+1% +$30.2K 0.82% 37
2017
Q2
$2.1M Buy
65,893
+13,676
+26% +$431K 0.79% 37
2017
Q1
$1.7M Sell
52,217
-9,144
-15% -$288K 0.69% 40
2016
Q4
$1.89M Buy
61,361
+4,219
+7% +$129K 0.82% 31
2016
Q3
$1.84M Sell
57,142
-1,729
-3% -$57.8K 0.77% 45
2016
Q2
$1.97M Sell
58,871
-17,604
-23% -$562K 0.81% 39
2016
Q1
$2.15M Sell
76,475
-11,957
-14% -$342K 0.85% 31
2015
Q4
$2.71M Buy
88,432
+31,383
+55% +$987K 1% 18
2015
Q3
$1.7M Sell
57,049
-1,658
-3% -$53.2K 0.77% 35
2015
Q2
$1.87M Sell
58,707
-771
-1% -$25.1K 0.89% 27
2015
Q1
$1.96M Buy
59,478
+1,892
+3% +$60.2K 0.94% 25
2014
Q4
$1.7M Buy
57,586
+5,897
+11% +$169K 0.84% 31
2014
Q3
$1.45M Sell
51,689
-473
-0.9% -$13.3K 0.72% 41
2014
Q2
$1.47M Buy
52,162
+1,243
+2% +$35.4K 0.66% 39
2014
Q1
$1.55M Sell
50,919
-1,311
-3% -$39.1K 0.7% 39
2013
Q4
$1.52M Sell
52,230
-1,812
-3% -$52.7K 0.67% 39
2013
Q3
$1.47M Sell
54,042
-1,511
-3% -$41.1K 0.67% 42
2013
Q2
$1.48M Buy
+55,553
New +$1.53M 0.7% 37

Other funds holding PFE

Wright Investors Service's PFE Position: Q2 2026 in Review

Wright Investors Service reduced its Pfizer (PFE) stake by 55% in Q2 2026, selling an estimated $1.07M and leaving 33,944 shares worth $817K. The position accounts for 0.22% of the portfolio, ranked #94.

Wright Investors Service first reported a position in PFE in Q2 2013 and has held it in 45 quarters since. The position peaked at $3.45M in Q2 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Wright Investors Service held 33,944 shares of Pfizer worth $817K as of Q2 2026.
  • Wright Investors Service sold 41,056 Pfizer shares in Q2 2026, an estimated $1.07M.
  • Pfizer made up 0.22% of Wright Investors Service's portfolio in Q2 2026, its #94 holding.
  • Wright Investors Service first reported a position in Pfizer in Q2 2013 and has held it in 45 quarters since.
  • Wright Investors Service's Pfizer position peaked at $3.45M in Q2 2022.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wright Investors Service's 13F filing for Q2 2026, filed 5 Aug 2026.